Reuters logo
BRIEF-EMA says starts safety review of Merck's Tredaptive drug
December 21, 2012 / 10:36 AM / 5 years ago

BRIEF-EMA says starts safety review of Merck's Tredaptive drug

LONDON, Dec 21 (Reuters) - EMA: * European medicines agency starts review of tredaptive, pelzont and trevaclyn

agency issues interim advice * Ema - started a review of the safety and efficacy of tredaptive, pelzont and

trevaclyn

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below